ROME Therapeutics的动态

#FOGBoston is less than 2 weeks away! There’s going to be lots of coverage of methods for how to make the most out of clinico-genomics. Another talk at #FOGBoston covering this topic is from, Jadwiga Bienkowska, Senior Director, Head of Computational Biology R&D, Pfizer She will be presenting ‘Unravelling Mechanisms of Resistance to CDK4/6i With the Power of ML Approaches and RWE Clinico-Genomics Data’, which will show the discovery of resistance mechanisms evolution trajectories and translation of resistance mechanisms between preclinical models and patients’ data. There’s still time to register: https://hubs.la/Q02s_nFS0

?? We are excited to announce that we support the Diagnostics-4-Future Conference in Kostanz on October 16-17, 2024. ???? ???? We look forward to meeting you there and discussing everything from biomarker discovery to new developments of biomarker panels for clinical use and diagnostics. #Diagnostics4Future #Biomarker #Diagnostics #Sciomics #Precisionmedicine #Biotechnology

I hope you can join the team at #IndicaLabs for this informative webinar on highly multiplexed IF workflows with HALO, presented by Dr. Anne Hellebust, Director of Product, Life Sciences. Register today for the event on the 25th. I hope to see you there! #digitalpathology

EDIT: Missed the chance to attend the webinar live? Get access to the VOD through the registration link below. --- Don’t miss our webinar on Organ-on-a-Chip and 3D bioprinting, featuring Professor Zaozao Chen from Southeast University! We have seen a great amount of interest for the upcoming webinar where Professor Zaozao Chen will present his group’s work on developing advanced biomimetic in vitro organ-on-a-chip models. These models can simulate human biology and can enable significant advancements in drug discovery research. ?? Date: October 23rd, 2:00 pm CST (China Standard Time), 3:00 pm JST, 11:30 am IST, 8 am CEST ?? Speaker: Professor Zaozao Chen, Southeast University Register here: https://lnkd.in/dBMRzwsE #Bioprinting #TissueEngineering #OrganOnAChip #DrugDiscovery #CancerResearch #AlternativeToAnimalTesting

???Check out the Editor's Choice #Review "Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs" ??by Virginia Metrangolo and Lars Engelholm Biotech Research & Innovation Centre (BRIC), University of Copenhagen K?benhavns Universitet - University of Copenhagen ??Link here: https://lnkd.in/evG8Bdif ??Antibody–drug conjugates (ADC) are targeted oncotherapeutics with the validated potential to create significant clinical impact. This comprehensive review covers the recent evolution of ADC design and development discussing molecular challenges and opportunities for further improvements.??

We’re excited to announce a new blog series, penned by our very own Study Director, Dr Nikola Kolundzic, Ph.D., diving deep into the world of bioengineered 3D human tissue models. This series will explore the power of REPROCELL 3D tissue engineering platform, powered by Alvetex technology. Here's what you can expect: ? Unveiling the significance of 3D human tissue models in drug discovery. ? Exploring the biological relevance, robustness, and predictive value of Alvetex models. ? Showcasing how these models can accelerate drug development and improve product safety. ? Whether you're a researcher or a biopharma professional, this series is for you! Gain valuable insights into how REPROCELL's innovative technology is transforming drug discovery and paving the way for personalized therapies. Read the first blog in the series here: https://hubs.li/Q02Wqg7D0

We’re excited to announce a new blog series, penned by our very own Study Director, Dr Nikola Kolundzic, Ph.D., diving deep into the world of bioengineered 3D human tissue models. This series will explore the power of REPROCELL 3D tissue engineering platform, powered by Alvetex technology. Here's what you can expect: ? Unveiling the significance of 3D human tissue models in drug discovery. ? Exploring the biological relevance, robustness, and predictive value of Alvetex models. ? Showcasing how these models can accelerate drug development and improve product safety. ? Whether you're a researcher or a biopharma professional, this series is for you! Gain valuable insights into how REPROCELL's innovative technology is transforming drug discovery and paving the way for personalized therapies. Read the first blog in the series here: https://hubs.li/Q02Wqg250

If you are working in drug discovery or work with knowledge graphs in any field - check out the following webinar tomorrow from my colleague Andreas Kramer. Its titled "Leveraging the QIAGEN Knowledge Graph and Causal Embeddings for Insights into Drug Repurposing". Timing: June 18, 2024 1:00 PM - 2:30 PM US EST Andreas will cover some of the following topics in his webinar: - How to connect diverse entities and relationships using biomedical knowledge graphs. - The potential of knowledge graphs to uncover new insights from existing data. - A machine learning-based approach utilizing causal interactions from the QIAGEN Knowledge Graph. - Predicting novel drug-disease relationships and constructing networks with relevant supporting evidence. You can register for the talk here: https://lnkd.in/gD-XV9ZV Reach out if you have questions or want to talk after. #DrugDiscovery #DataScience #Webinar #QIAGEN #DrugRepurposing #LifeSciences #ResearchInnovation

?????????????????????????????? ???????????????????? ?????? ?????????????? ????????????: ???????????????????????? ?????????????? ?????????????? ???????? ?????????????? On 07th May, the IVAM Microtechnology Network will present technologies that have transitioned from fantasies in science fiction movies to actual technological reality. Which technologies were imagined or depicted in films several years or decades ago? What was once pure technological fantasy in the past and is reality today? I am honored to chair the extraordinary session on “Innovative Visions - Advancing Medtech for the Next Era”, highlighting our unwavering dedication to revolutionize vascular access and transform patient safety, bringing it to our daily reality at Ebnet Medical. I invite you to join me, along with a remarkable lineup of medtech innovators, such as Dr. Ulisses Jesús Gutiérrez Hernández from FlowBeams and the University of Twente, presenting the development of a needle-free injection technology. Additionally, Eilien Heinrich from Fraunhofer IMM and Nicolas Schierbaum from Fraunhofer-Institute for Microelectronic Circuits and Systems will talk about advanced microtechnologies for single cell analysis in RNA-based cell and gene therapies. Lastly, Dr. Jochen Hoffmann from Bosch Research will present the decentralized molecular diagnostics platform Vivalytic. Let's innovate, collaborate, and revolutionize healthcare and patient safety together. Empathy and practical experience are key! https://lnkd.in/eEkVBvnW #vascularaccess #infusiontherapy #innovation #patientcare #patientsafety #medtech #event

Poly-Dtech are revolutionising scientific research and medical diagnosis with their high-performance fluorescent nanoparticles. Developed over ten years of collaboration between experts from France and Hong Kong, these state-of-the-art lanthanide-based nanoparticles offer unparalleled detection sensitivity. Their unique characteristics enable the identification of biomarkers at previously undetectable levels across various samples and concentrations. Designed with user-friendly protocols, Poly-Dtech's technology enhances molecular and cellular biology techniques, opening new possibilities in healthcare and life sciences. Discover how Poly-Dtech is advancing biomarker detection to new heights ?? https://buff.ly/3y8BxCY